Ark Invest Backs SPAC Merger For Quantum-Si, A Company Founded By Butterfly Network's Jonathan Rothberg
Ark Invest Backs SPAC Merger For Quantum-Si, A Company Founded By Butterfly Network's Jonathan Rothberg
A SPAC deal announced Thursday will see a company working on a new protein sequencing on a chip go public.
周四宣布的SPAC协议将使一家在芯片上开发新蛋白质测序的公司上市。
The SPAC Deal: Semiconductor company Quantum-Si is going public in a SPAC merger with HighCape Capital Acquisition Corp (NASDAQ:CAPA).
The deal values Quantum-Si at $925 million. An oversubscribed PIPE of $425 million included investment from accounts advised by Ark Invest, the firm led by Cathie Wood. PIPE investors will own 29.1% of the company after the merger.
该交易估值Quantum-Si为9.25亿美元。4.25亿美元的超额认购PIPE包括来自凯茜·伍德领导的Ark Invest所咨询的账户的投资。PIPE 投资者 将拥有 合并后持有公司29.1％的股份。
Shares will trade as "QSI" on the Nasdaq if the merger is approved. Current HighCape Capital Acquisition shareholders will own 7.9% of the new company.
如果合并获得批准，股票将在纳斯达克以 “QSI” 的形式交易。目前的HighCape资本收购股东将拥有这家新公司7.9％的股份。
About Quantum-Si: Planning to launch a chip-based proteomics solution, Quantum-Si believes it can change the protein and genomics markets.
关于 Quantum-Si：计划推出基于芯片的蛋白质组学解决方案，Quantum-Si认为它可以改变蛋白质和基因组学市场。
Quantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics.
Quantum-Si 创建了第一个下一代蛋白质测序平台，目标是彻底改变蛋白质组学领域。
The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.
该公司将从解码生命分子开始，首先解码有可能将规模扩大到基因组学的蛋白质。
The company is led by Dr. Jonathan Rothberg, who is also the founder of Butterfly Network Inc (NYSE:BFLY). Rothberg founded over 10 companies and is an award winner in the technology and medical fields. Butterfly Network, which is backed by Bill Gates, recently completed its SPAC merger.
Growth Ahead: A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use.
未来增长：Quantum-Si计划于2022年商业上市，首先是研究用途。
The company is targeting a $21 billion market. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.
该公司的目标是210亿美元的市场。Quantum-Si芯片的应用可能包括诊断应用和药物发现。
Quantum-Si uses protein to show what is happening instead of DNA which shows what could happen, according to the company’s presentation.
根据该公司的介绍，Quantum-Si使用蛋白质来显示正在发生的事情，而不是DNA来显示可能发生的事情。
The company believes it has a scalable semiconductor chip that could expand to home testing sometime after the year 2024.
该公司认为，它拥有可扩展的半导体芯片，该芯片可能会在2024年之后的某个时候扩展到家庭测试。
Financials: Quantum-Si is a pre-revenue company with no revenue anticipated until 2022. The company sees revenue of $17 million in fiscal 2022. The fiscal years of 2023, 2024 and 2025 have respective revenue projections of $49 million, $104 million and $186 million.
财务：Quantum-Si是一家未有收入的公司，预计要到2022年才有收入。该公司预计，2022财年的收入为1,700万美元。2023年、2024年和2025财年的收入预测分别为4,900万美元、1.04亿美元和1.86亿美元。
By 2025, Quantum-Si anticipates it can have over 5,000 devices installed.
Quantum-Si预计，到2025年，它可以安装超过5,000台设备。
Price Action: Shares of HighCape Capital Acquisition are up 51% to $15.70 in early Thursday trading.
价格走势：周四早些时候，HighCape Capital Acital Acupital收购的股价上涨51％，至15.70